To Compare the Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin Among Dyslipidemic Diabetic Patients at a Tertiary Centre in Bihar . Journal of Pharmaceutical Negative Results 2023, 672-676. https://doi.org/10.47750/pnr.2023.14.03.087.